- Pancrelipase
-
Pancrelipase Clinical data AHFS/Drugs.com monograph MedlinePlus a604035 Pregnancy cat. ? Legal status ? Routes Oral Identifiers CAS number 53608-75-6 ATC code A09AA02 DrugBank DB00085 UNII FQ3DRG0N5K Chemical data Formula C5850H8902N1606O1739S49 Mol. mass 131 kDa (what is this?) (verify) Pancrelipase is a form of enzyme therapy for the treatment of various digestive disorders, primarily exocrine pancreatic insufficiency. It is a mixture of three digestive enzymes, amylase, trypsin, and lipase, which are normally produced by the pancreas. Pancrelipase is a form of pancreatin having a elevated content of lipase.
Contents
Use
Pancrelipase is used by patients suffering from cystic fibrosis, chronic pancreatitis and after pancreatectomy.
Brand names for Pancrelipase include Creon, Pancrease, Ultrase, Mezym and Ozym.
Creon
Creon is a Pancrelipase manufactured and produce by Abbott Laboratories. Its available in different packaging ie Creon 5, 10 or 20.
Creon 10,000 mini-microspeheres (delayed release capsules) is available in China, Singapore, Malaysia and Thailand with enzyme contains lipase 10,000 u, amylase 8,000 u, protease 600 u.[1]
Its main indication is for patients with pancretic exocrine insufficiency ie, cystic fibrosis, chronic pancreatitis, pancreatectomy, pancreatic cancer and gastrotectomy.
References
- ^ "Creon 10000: Drug information, CME and news". MIMS.com. http://www.mims.com/Creon%2010000.html. Retrieved 2011-11-06.
External links
Digestives, including enzymes (A09) Enzymes Acid preparations This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.